• Subscribe
  • Magazine
  • Past Issues
  • Surveys
  • Industry Statistics
  • About Us
  • Members Only
  • Best Places to Work
    • Recent Quotes
    My Watchlist
    Indicators
    PennEnergy Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Champions Oncolog (NQ: CSBR )

    4.340 -0.160 (-3.56%)
    Streaming Delayed Price Updated: 10:41 AM EDT, Aug 29, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 6,915
    Open 4.408
    Bid (Size) 4.250 (2)
    Ask (Size) 4.480 (2)
    Prev. Close 4.500
    Today's Range 4.340 - 4.408
    52wk Range 3.970 - 7.130
    Shares Outstanding 13,415,066
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    CSBR Stock Earnings: Champions Oncology Beats EPS, Beats Revenue for Q4 2024
    CSBR stock results show that Champions Oncology beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2024. 
    Via InvestorPlace
    Champions Oncology Reports Quarterly Revenue of $14.0 Million
    Via ACCESSWIRE

    Performance

    YTD
    -25.04%
    -25.04%
    1 Month
    -12.85%
    -12.85%
    3 Month
    -5.86%
    -5.86%
    6 Month
    -26.44%
    -26.44%
    1 Year
    -33.44%
    -33.44%

    More News

    Read More
    Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Thursday, July 18, 2024
    Via ACCESSWIRE
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    Champions Oncology: Q3 Earnings Insights
    Via Benzinga
    Earnings Outlook For Champions Oncology
    Via Benzinga
    Recap: Champions Oncology Q2 Earnings
    Via Benzinga
    Champions Oncology and Medicines Discovery Catapult Forge Partnership to Accelerate Radiopharmaceutical Therapeutics Development
    Via ACCESSWIRE
    Champions Oncology Reports Quarterly Revenue of $12.0 Million
    Via ACCESSWIRE
    Earnings Scheduled For March 12, 2024
    Via Benzinga
    Champions Oncology's US Laboratory has Acquired Distinguished CAP Accreditation
    Via ACCESSWIRE
    Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 12, 2024
    Via ACCESSWIRE
    Insiders Buying Solid Biosciences And 2 Other Stocks
    Via Benzinga
    Insiders Buying Tilly's And 2 Other Stocks
    Via Benzinga
    Why Is RiskOn International (ROI) Stock Up 28% Today?
    Via InvestorPlace
    CSBR Stock Earnings: Champions Oncology Beats EPS, Misses Revenue for Q2 2024
    Via InvestorPlace
    Champions Oncology Reports Quarterly Revenue of $11.6 Million
    Via ACCESSWIRE
    Earnings Scheduled For December 12, 2023
    Via Benzinga
    Johnson Controls, Oracle And 3 Stocks To Watch Heading Into Tuesday
    Via Benzinga
    Investor Optimism Improves Further Ahead Of Inflation Data; Dow Gains For Third Straight Day
    Via Benzinga
    Topics Economy Stocks
    Exposures Interest Rates US Equities
    Champions Oncology to Announce Second Quarter Financial Results on Tuesday, December 12, 2023
    Via ACCESSWIRE
    Champions Oncology's European Research Operations Site Receives ISO-9001:2015 Accreditation and ATS Certification
    Via ACCESSWIRE
    Champions Oncology Announces the Addition of Brady Davis as President
    Via ACCESSWIRE
    Champions Oncology Reports Quarterly Revenue of $12.6 Million
    Via ACCESSWIRE
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.